BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 17904683)

  • 41. Changes in insulin resistance and cardiovascular risk induced by PPARgamma activation have no impact on RBP4 plasma concentrations in nondiabetic patients.
    Pfützner A; Schöndorf T; Hanefeld M; Lübben G; Kann PH; Karagiannis E; Wilhelm B; Forst T
    Horm Metab Res; 2009 Mar; 41(3):202-6. PubMed ID: 19224430
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum retinol-binding protein 4 is inversely correlated with disease severity of chronic hepatitis C.
    Huang JF; Dai CY; Yu ML; Shin SJ; Hsieh MY; Huang CF; Lee LP; Lin KD; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Chuang WL
    J Hepatol; 2009 Mar; 50(3):471-8. PubMed ID: 19155083
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.
    Yoo J; Lee S; Kim K; Yoo S; Sung E; Yim J
    Diabetes Res Clin Pract; 2008 Sep; 81(3):321-6. PubMed ID: 18571268
    [TBL] [Abstract][Full Text] [Related]  

  • 44. RBP-to-retinol ratio, but not total RBP, is elevated in patients with type 2 diabetes.
    Erikstrup C; Mortensen OH; Nielsen AR; Fischer CP; Plomgaard P; Petersen AM; Krogh-Madsen R; Lindegaard B; Erhardt JG; Ullum H; Benn CS; Pedersen BK
    Diabetes Obes Metab; 2009 Mar; 11(3):204-12. PubMed ID: 19215278
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Liver function critically determines serum retinol-binding protein 4 (RBP4) levels in patients with chronic liver disease and cirrhosis.
    Tacke F; Weiskirchen R; Trautwein C
    Hepatology; 2008 Nov; 48(5):1724-5; author reply 1725-6. PubMed ID: 18972556
    [No Abstract]   [Full Text] [Related]  

  • 46. Factors affecting the serum levels of adipokines in Korean male patients with nonalcoholic fatty liver disease.
    Cho YK; Lee WY; Oh SY; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Kim SW; Oh KW; Yun EJ; Oh ES
    Hepatogastroenterology; 2007; 54(77):1512-6. PubMed ID: 17708287
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of nonalcoholic fatty liver disease on the development of metabolic disorders.
    Fan JG; Li F; Cai XB; Peng YD; Ao QH; Gao Y
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1086-91. PubMed ID: 17608855
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The association of new inflammatory markers with type 2 diabetes mellitus and macrovascular complications: a preliminary study.
    Zhang M; Chen P; Chen S; Sun Q; Zeng QC; Chen JY; Liu YX; Cao XH; Ren M; Wang JK
    Eur Rev Med Pharmacol Sci; 2014 Jun; 18(11):1567-72. PubMed ID: 24943964
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
    Prashanth M; Ganesh HK; Vima MV; John M; Bandgar T; Joshi SR; Shah SR; Rathi PM; Joshi AS; Thakkar H; Menon PS; Shah NS
    J Assoc Physicians India; 2009 Mar; 57():205-10. PubMed ID: 19588648
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alterations of retinol-binding protein 4 species in patients with different stages of chronic kidney disease and their relation to lipid parameters.
    Henze A; Frey SK; Raila J; Scholze A; Spranger J; Weickert MO; Tepel M; Zidek W; Schweigert FJ
    Biochem Biophys Res Commun; 2010 Feb; 393(1):79-83. PubMed ID: 20097162
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
    Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
    Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of piglitazone and metformin on retinol-binding protein-4 and adiponectin in patients with type 2 diabetes mellitus complicated with non-alcohol fatty acid liver diseases.
    Yang L; Song MQ; Zhang QL; Shou L; Zang SF; Yang YL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Jun; 36(3):309-12. PubMed ID: 24997826
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retinol binding protein 4 in dairy cows: its presence in colostrum and alteration in plasma during fasting, inflammation, and the peripartum period.
    Abd Eldaim MA; Kamikawa A; Soliman MM; Ahmed MM; Okamatsu-Ogura Y; Terao A; Miyamoto T; Kimura K
    J Dairy Res; 2010 Feb; 77(1):27-32. PubMed ID: 19785912
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes.
    Narasimhan S; Gokulakrishnan K; Sampathkumar R; Farooq S; Ravikumar R; Mohan V; Balasubramanyam M
    Clin Biochem; 2010 Jul; 43(10-11):815-21. PubMed ID: 20398645
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coronary artery disease is associated with higher epicardial retinol-binding protein 4 (RBP4) and lower glucose transporter (GLUT) 4 levels in epicardial and subcutaneous adipose tissue.
    Salgado-Somoza A; Teijeira-Fernández E; Rubio J; Couso E; González-Juanatey JR; Eiras S
    Clin Endocrinol (Oxf); 2012 Jan; 76(1):51-8. PubMed ID: 21645024
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phospholipid transfer protein activity is determined by type 2 diabetes mellitus and metabolic syndrome, and is positively associated with serum transaminases.
    Dullaart RP; de Vries R; Dallinga-Thie GM; Sluiter WJ; van Tol A
    Clin Endocrinol (Oxf); 2008 Mar; 68(3):375-81. PubMed ID: 17877759
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease.
    Suh JB; Kim SM; Cho GJ; Choi KM
    Scand J Gastroenterol; 2014 Aug; 49(8):979-85. PubMed ID: 24957697
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Retinol binding protein 4 and insulin resistance in apparently healthy elderly subjects.
    Lee JW; Im JA; Park KD; Lee HR; Shim JY; Lee DC
    Clin Chim Acta; 2009 Feb; 400(1-2):30-2. PubMed ID: 18977339
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adipokines in type 1 diabetes after successful pancreas transplantation: normal visfatin and retinol-binding-protein-4, but increased total adiponectin fasting concentrations.
    Stadler M; Storka A; Theuer EA; Krebs M; Vojtassakova E; Nowotny P; Pacini G; Kästenbauer T; Luger A; Prager R; Wolzt M; Anderwald C
    Clin Endocrinol (Oxf); 2010 Jun; 72(6):763-9. PubMed ID: 19769621
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship between serum retinol-binding protein 4 and visfatin and the metabolic syndrome.
    Lin CC; Lai MM; Li TC; Li CI; Liu CS; Chen CC; Wu MT
    Diabetes Res Clin Pract; 2009 Jul; 85(1):24-9. PubMed ID: 19403191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.